Crossref
Suzetrigine (Journavx) for a Wide Range of Super‐refractory Chronic Pain Syndromes: A Case Series
PM&R · 2026-11 · 18 (S3)
DOI: 10.1002/pmrj.255_70259 ↗Kurz gefasst
Fachartikel in der Zeitschrift PM&R, online erschienen am 10.11.2026. Verfasst von Tianrun Pan und 1 weiteren Autor:innen.
Themen: Schmerzmanagement
Abstract (Originalsprache)
reflect greater axonal injury rather than an independent EDX marker of CRPS II.
Zitieren
APA
Pan, T., & Hascalovici, J. (2026). Suzetrigine (Journavx) for a Wide Range of Super‐refractory Chronic Pain Syndromes: A Case Series. PM&R, 18(S3). https://doi.org/10.1002/pmrj.255_70259
Vancouver
Pan T, Hascalovici J. Suzetrigine (Journavx) for a Wide Range of Super‐refractory Chronic Pain Syndromes: A Case Series. PM&R. 2026;18(S3). doi:10.1002/pmrj.255_70259
BibTeX
@article{Pan2026,
author = {Pan, Tianrun and Hascalovici, Jacob},
title = {Suzetrigine (Journavx) for a Wide Range of Super‐refractory Chronic Pain Syndromes: A Case Series},
journal = {PM&R},
year = {2026},
volume = {18},
number = {S3},
doi = {10.1002/pmrj.255_70259}
}
EUVIMED